Adipose tissue contains high concentrations of aromatase, which reduces testosterone concentrations by converting it to estradiol. Figure 2 illustrates the main hypogonadal-obesity-insulin resistance connections and also includes other factors such as TNF-α (an adipokine), which is elevated in obese males (42,51,57,58). Thus, adiposity potentially leads to hypogonadism, which itself promotes further adiposity. The estradiol produced by aromatisation also provides negative feedback on the HPG axis, further reducing testosterone. As discussed below, a measurement of low testosterone in a patient should be reconfirmed at a later stage before considering treatment. This is probably because there is subject-to-subject variation in testosterone secretion and in the testosterone threshold where symptoms become manifest. In the Baltimore Longitudinal Study on Ageing, it was found that 19% of men over 60 years had low testosterone. In general, however, the term mixed hypogonadism is not used in clinical practice in the US and is considered part of secondary hypogonadism. Certain medications and illnesses can also affect the hypothalamic–pituitary system resulting in hypogonadism (17). However, studies of [testosterone order](https://rotatesex3.bravejournal.net/how-to-get-a-trt-prescription-and-buy-testosterone-online) therapy in men with osteoporosis are limited and none have used fractures as an end-point; so although there is significant evidence of an association between hypogonadism and osteoporosis, there is no established causal link between the two. Interventional studies have shown that testosterone replacement therapy in hypogonadal males increased spine BMD and trabecular connectivity (61,67). Hip fracture incidence is low until after 75 years, when the risk increases exponentially. Up to 13 million men are at increased risk because of low BMD and up to 2 million of these have osteoporosis (61,62). The mechanism underlying the insulin sensitising effects of testosterone needs to be elucidated. The withdrawal of testosterone therapy in hypogonadal patients that had been stabilised on this therapy leads to an increase in insulin resistance within 2 weeks and prior to significant weight gain (59). However, it seems likely that testosterone may suppress insulin resistance independently of its effects on adiposity. A board-certified urologist who specializes in men’s hormone care These metabolic benefits weren’t automatic, though—lifestyle factors like strength training, diet, and [output.jsbin.com](https://output.jsbin.com/qifoseceqa/) sleep quality still played a critical role. The normal men did not have an increase in adjusted BMR. The percent increase in LBM was similar in men with muscular dystrophy (+10%) and normal men (+11%). 2020 guidelines from the American College of Physicians support the discussion of testosterone treatment in adult men with age-related low levels of testosterone who have sexual dysfunction. In androgen-deficient men with concomitant autoimmune thyroiditis, substitution therapy with testosterone leads to a decrease in thyroid autoantibody titres and an increase in thyroid's secretory capacity (SPINA-GT). In people who have undergone testosterone deprivation therapy, testosterone increases beyond the castrate level have been shown to increase the rate of spread of an existing prostate cancer. Adult testosterone effects are more clearly demonstrable in males than in females, but are likely important to both sexes. These include adult-type body odor, increased oiliness of skin and hair, acne, pubarche (appearance of pubic hair), axillary hair (armpit hair), growth spurt, accelerated bone maturation, and facial hair. For postnatal effects in both males and females, these are mostly dependent on the levels and duration of circulating free testosterone. Since [purchase testosterone](https://topbookmarks.cloud/item/591848) levels decrease as men age, testosterone is sometimes used in older men to counteract this deficiency.